The global orthopedic implants market is projected to reach $76.4 billion by 2033, according to a report published by Allied Market Research. The market was valued at $49.4 billion in 2023, with a compound annual growth rate (CAGR) of 4.4% expected from 2024 to 2033.
Several factors are driving the growth of the orthopedic implants market. The rise in the prevalence of orthopedic disorders, along with technological advancements in the field of orthopedic implants, has contributed to the surge in demand for these medical devices. However, the high cost of orthopedic implants and complications associated with the implant procedure are limiting market growth.
The report highlights the dominance of the reconstructive joint replacements segment in the market. This segment accounted for the largest market share in 2023, driven by the increasing prevalence of degenerative joint diseases such as osteoarthritis. Advancements in implant materials, surgical techniques, and prosthetic designs have also improved the outcomes and longevity of joint replacement procedures.
In terms of biomaterial, metallic biomaterials held the largest market share in 2023. These materials offer superior mechanical properties, including high strength and durability, which are crucial for load-bearing applications. Metallic biomaterials such as titanium and stainless steel also exhibit excellent biocompatibility and corrosion resistance, making them ideal for long-term implantation.
The knee segment dominated the market share in 2023 and is expected to maintain its leadership status during the forecast period. Increased awareness about the benefits of knee replacement surgery among patients and healthcare providers has contributed to the growing demand. Advancements in surgical techniques, implant designs, and materials have made knee replacement procedures more effective and accessible to a broader range of patients.
North America held the largest market share in 2023 and is expected to maintain its dominance by 2035. The region benefits from advanced healthcare infrastructure, significant investments in research and development, and a rise in the prevalence of orthopedic conditions among an aging population. The presence of leading market players and favorable reimbursement policies further enhance market growth.
Key players in the orthopedic implants market include Arthrex, Inc., Colfax Corporation (DJO, LLC), CONMED CORPORATION, GLOBUS MEDICAL INC., Johnson & Johnson (DEPUY SYNTHES), Medtronic Plc, NuVasive Inc., Smith & Nephew plc, Stryker Corporation, and Zimmer Biomet Holdings Inc. These companies have adopted various strategies such as new product launches and innovation to increase their market share and maintain dominance.
The orthopedic implants market presents significant growth opportunities, particularly in emerging markets. Despite the challenges posed by the high cost of implants and complications with the implant procedure, the market is expected to expand due to the increasing prevalence of orthopedic disorders and advancements in implant technology. With the continuous development of new materials and surgical techniques, the orthopedic implants market is poised for further growth in the coming years.